ArticleProceedings of the National Academy of Sciences of the United States of America2008
Overcoming obstacles to the effective immunotherapy of human cancer.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
23 citing papers in PubMed.
- Trial
- Overcoming immunotherapy resistance in non-small cell lung cancer: a narrative review of related factors.Immunotherapy · 2025Review
- Tumor extracellular vesicle-derived PD-L1 promotes T cell senescence through lipid metabolism reprogramming.Science translational medicine · 2025Article
- Article
- Article
- Combined induction with anti-PD-1 and anti-CTLA-4 antibodies provides synergistic antitumor effects in DC-CIK cells in renal carcinoma cell lines.International journal of clinical and experimental pathology · 2019Article
- Novel T cells with improved in vivo anti-tumor activity generated by RNA electroporation.Protein & cell · 2017Article
- Endostatin enhances antitumor effect of tumor antigen-pulsed dendritic cell therapy in mouse xenograft model of lung carcinoma.Chinese journal of cancer research = Chung-kuo yen cheng yen chiu · 2016Article
- Effect of inhibition proliferation in human lung adenocarcinoma A549 cells by cytokine-induced killer cells.Thoracic cancer · 2015Article
- Antiangiogenic therapy improves the antitumor effect of adoptive cell immunotherapy by normalizing tumor vasculature.Medical oncology (Northwood, London, England) · 2013Review
- Host b7x promotes pulmonary metastasis of breast cancer.Journal of immunology (Baltimore, Md. : 1950) · 2013Article
- IL-21 promotes the expansion of CD27+ CD28+ tumor infiltrating lymphocytes with high cytotoxic potential and low collateral expansion of regulatory T cells.Journal of translational medicine · 2013Article
- High-avidity T cells are preferentially tolerized in the tumor microenvironment.Cancer research · 2013Article
- Combining antiangiogenic therapy with adoptive cell immunotherapy exerts better antitumor effects in non-small cell lung cancer models.PloS one · 2013Article
- Demethylation of cancer/testis antigens and CpG ODN stimulation enhance dendritic cell and cytotoxic T lymphocyte function in a mouse mammary model.BioMed research international · 2013Article
- A combination of local inflammation and central memory T cells potentiates immunotherapy in the skin.Journal of immunology (Baltimore, Md. : 1950) · 2012Article
- Immunological treatment options for locoregionally advanced head and neck squamous cell carcinoma.International reviews of immunology · 2012Review
- EGFR-homing dsRNA activates cancer-targeted immune response and eliminates disseminated EGFR-overexpressing tumors in mice.Clinical cancer research : an official journal of the American Association for Cancer Research · 2011Article
- Transduction of SIV-specific TCR genes into rhesus macaque CD8+ T cells conveys the ability to suppress SIV replication.PloS one · 2011Article
- Antiangiogenic agents can increase lymphocyte infiltration into tumor and enhance the effectiveness of adoptive immunotherapy of cancer.Cancer research · 2010Article
Corrections and comments
- Comment on
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.